We train and inspire the next generation of health care leaders to improve health care delivery systems and mitigate public health risks around the world.
More people living with HIV and enrolled in Medicare are taking modern, less toxic antiretroviral drugs than ever before, according to a new study led by Harvard Chan School. This progress may be upended by recent federal funding cuts to HIV prevention and care programs, however.
As Congress considers cutting billions from Medicaid, experts at Harvard Chan School say such cuts could have profound negative impacts on the health of the roughly 72 million Americans with low incomes or disabilities served by the joint federal-state health insurance program, and on the health providers who serve them.
One hundred days into the new federal administration, a new poll led by researchers at Harvard Chan School reports that major segments of the U.S. public anticipate they will lose trust in public health recommendations with the changes in health agency leadership.
Amid the COVID-19 pandemic, the U.S. government made record time in facilitating the invention, approval, and distribution of lifesaving vaccines. Eric Hargan, then-deputy secretary of the U.S. Department of Health and Human Services, shared his insider’s perspective on how.
Harvard Chan projects yielding new insights into disability benefits, trainings for first responders in humanitarian crises, and a model to measure discrimination’s impact on health, have lost federal funding.
There are significant differences in the costs and durations of radiotherapy treatment for cancer, depending on whether a patient is insured by traditional Medicare or Medicare Advantage, according to a new study by health policy researchers at Harvard Chan School.
